Further investigation on the reasons for contents of paeoniflorin in commercial Radix Paeoniae Alba of prepared Chinese crude drug lower than the standard of Chinese Pharmacopeia

LIU Jing-jing1,2,3, LIU Xiao1,2,3, CAI Hao1,2,3, LI Song-lin4, CAI Bao-chang1,2,3,4

Chinese Journal of Pharmaceutical Analysis ›› 2010, Vol. 30 ›› Issue (10) : 1817-1821.

Chinese Journal of Pharmaceutical Analysis ›› 2010, Vol. 30 ›› Issue (10) : 1817-1821.

Further investigation on the reasons for contents of paeoniflorin in commercial Radix Paeoniae Alba of prepared Chinese crude drug lower than the standard of Chinese Pharmacopeia

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2010, 30(10): 1817-1821

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/